Articles On Cann Group (ASX:CAN)

Medical cannabis player is raising funds to support working capital needs and to strengthen its manufacturing capability.

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

The unfolding fraud drama involving Sydney-based lease financing company, Forum Finance, has caught some of  the world’s biggest banks by surprise. On July 2, Westpac Bank (ASX:WBC) blew the whistle on a potential fraud committed by its cli...

This week Technicorum Holdings announced an upcoming token sale and launch of The CanCoin – a cannabis token designed to solve market friction and monetisation in the European cannabis market and to help build blockchain-based solutions for...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

The 2021 financial year was overall a very good one for ASX shares. The S&P/ASX 200 Index (ASX: XJO) managed to put on a performance of 24% for the 12 months to 30 June 2021. That makes FY2021 one of the best financial years ever for t...

Cannabis stocks have welcomed the change in ownership of Pershing Australia from Bank of New York Mellon (BNYM) to Finclear Pty Ltd which – effective immediately – will allow the trading of cannabis securities on the ASX. In late 2019, BNYM...

The Bod Australia Ltd (ASX: BDA) share price is a strong performer today following the release of a sales update. At the time of writing, shares in the CBD and hemp healthcare products company are up 3% to 35 cents. What’s driving the Bod...

The Althea Group Holdings Ltd (ASX: AGH) share price has been a positive performer on Wednesday. In early trade, the cannabis company’s shares are up 4.5% to 33.5 cents. Why is the Althea share price on a high today? Investors have been bu...

ShareCafeCann Group (ASX: CAN) – Hidden Gems Webinar Presenter – Shane Duncan – Chief Operating Officer – Cann Group’s vision is to provide access to a range of medicinal cannabis products for patients in Australia and globally.     Cann G...

ShareCafeHidden Gems Webinar Recap – Fresh Leaf Analytics, LGP, CAN, AGH & EMD Catch up on the full webinar with presentations from Fresh Leaf Analytics, Little Green Pharma (ASX: LGP), Cann Group (ASX: CAN) , Althea Group (ASX: AGH),...

The company’s current drug registration programs span its EMD-003 CBD medicine targeting mental health, EMD-004 for IBS and EMDMA-001 MDMA psychedelic-assisted therapy program targeting sufferers of treatment-resistant PTSD.

The US cannabis sector received a big lift after Amazon announced that job applicants at its offices and warehouses will no longer be drug-tested for marijuana use. Delivery drivers, however, will still be tested. The company also said it w...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

There was plenty of action in the US regulatory front within the cannabis sector this week. A couple of major legislations during the week could potentially shake up the US cannabis industry. The Marijuana Opportunity Reinvestment and Expun...

The Cann Group Ltd (ASX: CAN) share price is falling during morning trade. This follows the cannabis company’s announcement of a revised revenue guidance for FY21. At the time of writing, Cann shares are exchanging hands for 43 cents, down...

In 2021, which of Europe and North America is the place to be for ASX cannabis stocks?   The case for Europe A few years ago there would’ve been no question that it was North America with Canada legalising recreational cannabis as well as h...

LBT Innovations (ASX:LBT) shares rose this morning after it sold its first two pathology sample analysers in the UK. LBT’s APAS Independence (Automated Plate Assessment System) sorts medical samples and uses AI and machine learning to deter...

A cannabis-based drug has been listed on Australia’s Pharmaceutical Benefits Scheme for the first time, as medical marijuana gains increased acceptance. The move means that an estimated 116 Aussies with a rare form of epilepsy known as Drav...

The outlook of the Horizons Marijuana Life Sciences Index ETF (HMMJ) reached a high for the week on Thursday, hitting 87.73% on the six-month performance chart before close of trading, after news broke that tobacco giant Philip Morris Inter...

The Cann Group Ltd (ASX: CAN) share price is holding its ground today despite announcing a product recall from one of its customers. During late afternoon trade, the cannabis company’s shares are fetching for 48.5 cents, up 1%. At one poin...

ASX pot stocks have run hot in recent months but eight in particular have been particularly rewarding for shareholders. Many pot stocks ran cold prior to COVID-19 as regulatory progress stalled and global markets didn’t take off. Australia...

April 20 has come and gone, but ASX cannabis companies aren’t getting that high — they’re actually low. Of the 36 pot companies in the space, 27 have lost ground over the last fortnight. Just seven have advanced. Gains were led by Wide Open...

Summary Emyria has received firm commitments in a well-supported placement to raise AU$5 million. The Company will use these funds to advance drug development and develop its product pipeline. The proceeds would also support the initi...

The number of medical cannabis prescriptions issued under Australia’s special access scheme just keeps on growing. There were a record 9,959 SAS Category B marijuana prescriptions issued in March, two and a half times the number from a year...

The S&P/ASX 200 Index (ASX: JXO) is having a pretty decent day today. A the time of writing, the ASX 200 is up a healthy pre-Easter 0.21%. But one group that is doing a quarter-ounce better are ASX cannabis shares. Take Creso Pharma Lt...

Australia’s medical marijuana industry is showing strong growth, according to an industry-leading biannual report. The Freshleaf Analytics report, released this morning, says that patient numbers have grown 15-fold over the past two and a h...

Emyria (ASX:EMD) and Cann Group (ASX:CAN) have announced a collaboration agreement under which they will seek accelerated registration of a low-dose cannabidiol (CBD) only capsule with the TGA.

The Cann Group Ltd (ASX: CAN) share price was out of form on Monday. The cannabis company’s shares fell 3.5% to 55 cents. This latest decline means the Cann share price is now down a disappointing 56% from its 52-week high. Why is the Cann...

Cann Group Ltd (ASX: CAN) shares opened slightly higher on Monday but have since retreated. This comes after the company announced a partnership with Emyria Ltd (ASX: EMD). At the time of writing, the Cann share price is trading 1.75% lowe...

Source:ShutterstockProfessional, Shutterstock Summary Althea Group Holdings Limited updated the market with a new and innovative range of its oil-based cannabis products. Cann Group and Emyria have entered in collaboration to accelera...

Cannabis companies Cann Group (ASX:CAN) and Emryia (ASX:EMD) are joining forces in a bid to be the first companies to have a low-dose cannabinoid (CBD) product approved for sale in Australian pharmacies without a prescription. They are hopi...

Source:ElRoi, Shutterstock Summary Cann Group is a $163.9 billion cannabis company focused on breeding, cultivating, manufacturing and supplying medicinal cannabis. AusCann Group is the smallest cannabis player in this list, with a ma...

If you’re travelling from Canada, Holland, certain US states, or any other parts of the world where recreational cannabis use has been legalised, step carefully if you plan to visit Japan. Japanese courts continue to enforce strict laws su...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Pot legalisation is creeping across the US state by state, and a major market could be about to join their ranks. Reports out of New York indicate that lawmakers in the Empire State are close to signing a new bill legalising recreational ca...

Source: Stereo Lights, Shutterstock Summary The Australian cannabis industry is in an infant stage and can offer several opportunities to market participants with a keen interest in this space. Developer and supplier of cannabis produ...

If you’re aiming to add some diversification to your portfolio in March, then you might want to look at exchange traded funds (ETFs). This is because they are an easy and effective way to achieve diversification as they give investors acce...

The transaction is consistent with Harvest One’s strategy to divest non-core assets, streamline operations and utilise strategic manufacturing partners to create efficiencies to support the company’s CPG business model.

Cann Group Ltd (ASX: CAN) shares are edging higher today following the release of the medicinal cannabis company’s financial results for the half year ending 31 December (H1 FY21). At the time of writing, the Cann Group share price is trad...

It looks like Cann Group (ASX:CAN) will be left with a $3.6 million loss in the wake of a devastating ... Read More The post Not covered: Cann Group on the hook for $3.6 million cybersecurity incident appeared first on Stockhead.

Summary Cann Group has reported revenue from net sales of $1.08 million and an operating loss of $9.4 million. After the end of the reported period, the company announced commitments to a minority investment in iuvo worth CA$1 million....

In what may be a catalyst for ASX cannabis shares, a private company today gained approval to grow medicinal cannabis in Western Australia. As reported by the ABC, the private medicinal cannabis company Elite Cannabinoids has received appr...

Eagle-eyed followers of ASX cannabis shares might have noticed something strange about the Cann Group Ltd (ASX: CAN) share price this morning. It wasn’t going anywhere. Cann shares closed at 78 cents yesterday after rising more than 36% at...

The first half of FY21 (1H FY21) saw positive developments for ASX cannabis shares surrounding the regulation of medicinal cannabis products both locally and internationally. International markets were buoyed by the down-scheduling of cann...

Cann Group (ASX:CAN) says it will make up to $7 million less than the $15 million in full-year revenue the ... Read More The post Cann Group lowers guidance, makes acquisition; Zelira to get new boss appeared first on Stockhead.

Summary An ethical leader in the emerging medical cannabis market, Cann Group, is set to acquire Satipharm business from Harvest One Cannabis. Cann is confident that Satipharm acquisition will help accelerate revenues and bolster its p...

15 Feb 2021 - Medicinal cannabis producer Cann Group (ASX:CAN) has sealed a deal to acquire Satipharm from Canadian-domiciled Harvest One Cannabis (CVE:HVT).

The Cann Group Ltd (ASX: CAN) share price is pushing higher today following the release of a couple of announcements. At the time of writing, the cannabis company’s shares are up 2.5% to 79 cents. Why is the Cann share price pushing higher...

Summary Medicinal cannabis products manufacturer Cann Group was at the centre of another cybersecurity incident to have hit Australian companies. The Company is in ongoing talks with its bank to see if it’s possible to halt the payment...